当前位置:
X-MOL 学术
›
Acta Pharmacol. Sin.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Author Correction: AZD9291 inactivates the PRC2 complex to mediate tumor growth inhibition.
Acta Pharmacologica Sinica ( IF 6.9 ) Pub Date : 2020-05-01 , DOI: 10.1038/s41401-019-0344-3 Kai-Li Zhang 1, 2 , Qian-Qian Shen 1 , Yan-Feng Fang 1 , Yi-Ming Sun 1 , Jian Ding 1 , Yi Chen 1
Acta Pharmacologica Sinica ( IF 6.9 ) Pub Date : 2020-05-01 , DOI: 10.1038/s41401-019-0344-3 Kai-Li Zhang 1, 2 , Qian-Qian Shen 1 , Yan-Feng Fang 1 , Yi-Ming Sun 1 , Jian Ding 1 , Yi Chen 1
Affiliation
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
中文翻译:
作者更正:AZD9291使PRC2复合物失活以介导肿瘤生长抑制。
该文件的修订版已经发布,可以通过文件顶部的链接进行访问。
更新日期:2020-02-14
中文翻译:
作者更正:AZD9291使PRC2复合物失活以介导肿瘤生长抑制。
该文件的修订版已经发布,可以通过文件顶部的链接进行访问。